Cargando…
Zinc Binding to NAP-Type Neuroprotective Peptides: Nuclear Magnetic Resonance Studies and Molecular Modeling
Aggregation of amyloid-β peptides (Aβ) is a hallmark of Alzheimer’s disease (AD), which is affecting an increasing number of people. Hence, there is an urgent need to develop new pharmaceutical treatments which could be used to prevent the AD symptomatology. Activity-dependent neuroprotective protei...
Autores principales: | Lupaescu, Ancuta-Veronica, Mocanu, Cosmin Stefan, Drochioiu, Gabi, Ciobanu, Catalina-Ionica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541368/ https://www.ncbi.nlm.nih.gov/pubmed/34681235 http://dx.doi.org/10.3390/ph14101011 |
Ejemplares similares
-
Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer’s Disease
por: Mocanu, Cosmin Stefan, et al.
Publicado: (2020) -
A computational study of metal ions interaction with amyloid-β 1–42 peptide structure in hyperpyrexia: Implications for Alzheimer disease
por: Mocanu, Cosmin Stefan, et al.
Publicado: (2022) -
Novel Design of Neuropeptide-Based Drugs with β-Sheet Breaking Potential in Amyloid-Beta Cascade: Molecular and Structural Deciphers
por: Mocanu, Cosmin Stefan, et al.
Publicado: (2022) -
NAP and D-SAL: neuroprotection against the β amyloid peptide (1–42)
por: Gozes, Illana, et al.
Publicado: (2008) -
The Use of Bioactive Compounds in Hyperglycemia- and Amyloid Fibrils-Induced Toxicity in Type 2 Diabetes and Alzheimer’s Disease
por: Lupaescu, Ancuta-Veronica, et al.
Publicado: (2022)